HEADER TRANSFERASE 21-NOV-12 4I24 TITLE STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 695-1022, EGFR KINASE DOMAIN; COMPND 5 SYNONYM: PROTO-ONCOGENE C-ERBB-1, RECEPTOR TYROSINE-PROTEIN KINASE COMPND 6 ERBB-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE DOMAIN, PHOSPHOTRASFER, ATP BINDING, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA,J.FENG,R.FERRE,K.RYAN,O.BRODSKY,A.STEWART REVDAT 2 27-FEB-13 4I24 1 JRNL REVDAT 1 16-JAN-13 4I24 0 JRNL AUTH K.S.GAJIWALA,J.FENG,R.FERRE,K.RYAN,O.BRODSKY,S.WEINRICH, JRNL AUTH 2 J.C.KATH,A.STEWART JRNL TITL INSIGHTS INTO THE ABERRANT ACTIVITY OF MUTANT EGFR KINASE JRNL TITL 2 DOMAIN AND DRUG RECOGNITION. JRNL REF STRUCTURE V. 21 209 2013 JRNL REFN ISSN 0969-2126 JRNL PMID 23273428 JRNL DOI 10.1016/J.STR.2012.11.014 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 102513.620 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.9 REMARK 3 NUMBER OF REFLECTIONS : 64068 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3268 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2110 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2090 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3450 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0040 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 67710 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8812 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 430 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4813 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 282 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.21000 REMARK 3 B22 (A**2) : -5.56000 REMARK 3 B33 (A**2) : -1.64000 REMARK 3 B12 (A**2) : -1.55000 REMARK 3 B13 (A**2) : -0.45000 REMARK 3 B23 (A**2) : 0.45000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.80 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.62 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.370 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.110 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.130 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 44.99 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP-TRUNCATED.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARA REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 TOPOLOGY FILE 1 : PROTEIN-TRUNCATED.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4I24 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-12. REMARK 100 THE RCSB ID CODE IS RCSB076207. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-SEP-10 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67776 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.5300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.51000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.12-0.14 M AMMONIUM ACETATE, 12-14% REMARK 280 PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2960 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 694 REMARK 465 SER A 695 REMARK 465 GLY A 696 REMARK 465 GLU A 697 REMARK 465 ALA A 698 REMARK 465 PRO A 699 REMARK 465 ARG A 748 REMARK 465 GLU A 749 REMARK 465 ALA A 750 REMARK 465 THR A 751 REMARK 465 SER A 752 REMARK 465 PRO A 753 REMARK 465 LYS A 754 REMARK 465 GLY A 863 REMARK 465 ALA A 864 REMARK 465 GLU A 865 REMARK 465 GLU A 866 REMARK 465 LYS A 867 REMARK 465 GLU A 868 REMARK 465 TYR A 869 REMARK 465 HIS A 870 REMARK 465 ALA A 871 REMARK 465 GLU A 872 REMARK 465 GLY A 873 REMARK 465 GLY A 874 REMARK 465 LYS A 875 REMARK 465 GLU A 1015 REMARK 465 TYR A 1016 REMARK 465 LEU A 1017 REMARK 465 ILE A 1018 REMARK 465 PRO A 1019 REMARK 465 GLN A 1020 REMARK 465 GLN A 1021 REMARK 465 GLY A 1022 REMARK 465 GLY B 694 REMARK 465 SER B 695 REMARK 465 GLY B 696 REMARK 465 GLU B 697 REMARK 465 ALA B 698 REMARK 465 PRO B 699 REMARK 465 GLY B 863 REMARK 465 ALA B 864 REMARK 465 GLU B 865 REMARK 465 GLU B 866 REMARK 465 LYS B 867 REMARK 465 GLU B 868 REMARK 465 TYR B 869 REMARK 465 HIS B 870 REMARK 465 ALA B 871 REMARK 465 GLU B 872 REMARK 465 GLY B 873 REMARK 465 GLU B 1015 REMARK 465 TYR B 1016 REMARK 465 LEU B 1017 REMARK 465 ILE B 1018 REMARK 465 PRO B 1019 REMARK 465 GLN B 1020 REMARK 465 GLN B 1021 REMARK 465 GLY B 1022 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 783 -127.48 -127.15 REMARK 500 ARG A 836 -14.46 80.82 REMARK 500 ASP A 837 43.98 -143.81 REMARK 500 GLU B 749 123.54 179.99 REMARK 500 THR B 783 -120.72 -130.87 REMARK 500 ASN B 808 20.05 -141.35 REMARK 500 ARG B 836 -16.04 80.92 REMARK 500 ASP B 837 46.50 -141.94 REMARK 500 MET B1002 14.06 -145.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 1C9 A 9001 REMARK 610 1C9 B 9001 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1C9 A 9001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1C9 B 9001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4I1Z RELATED DB: PDB REMARK 900 RELATED ID: 4I20 RELATED DB: PDB REMARK 900 RELATED ID: 4I21 RELATED DB: PDB REMARK 900 RELATED ID: 4I22 RELATED DB: PDB REMARK 900 RELATED ID: 4I23 RELATED DB: PDB DBREF 4I24 A 695 1022 UNP P00533 EGFR_HUMAN 695 1022 DBREF 4I24 B 695 1022 UNP P00533 EGFR_HUMAN 695 1022 SEQADV 4I24 GLY A 694 UNP P00533 EXPRESSION TAG SEQADV 4I24 MET A 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQADV 4I24 GLY B 694 UNP P00533 EXPRESSION TAG SEQADV 4I24 MET B 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQRES 1 A 329 GLY SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE SEQRES 2 A 329 LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SEQRES 3 A 329 SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE SEQRES 4 A 329 PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS SEQRES 5 A 329 GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU SEQRES 6 A 329 ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN SEQRES 7 A 329 PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER SEQRES 8 A 329 THR VAL GLN LEU ILE MET GLN LEU MET PRO PHE GLY CYS SEQRES 9 A 329 LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SEQRES 10 A 329 SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS SEQRES 11 A 329 GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG SEQRES 12 A 329 ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN SEQRES 13 A 329 HIS VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU LEU SEQRES 14 A 329 GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS SEQRES 15 A 329 VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS SEQRES 16 A 329 ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY SEQRES 17 A 329 VAL THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO SEQRES 18 A 329 TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU SEQRES 19 A 329 GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR SEQRES 20 A 329 ILE ASP VAL TYR MET ILE MET VAL LYS CYS TRP MET ILE SEQRES 21 A 329 ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE SEQRES 22 A 329 GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU SEQRES 23 A 329 VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO SEQRES 24 A 329 THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU SEQRES 25 A 329 ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE SEQRES 26 A 329 PRO GLN GLN GLY SEQRES 1 B 329 GLY SER GLY GLU ALA PRO ASN GLN ALA LEU LEU ARG ILE SEQRES 2 B 329 LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL LEU GLY SEQRES 3 B 329 SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU TRP ILE SEQRES 4 B 329 PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA ILE LYS SEQRES 5 B 329 GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN LYS GLU SEQRES 6 B 329 ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL ASP ASN SEQRES 7 B 329 PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU THR SER SEQRES 8 B 329 THR VAL GLN LEU ILE MET GLN LEU MET PRO PHE GLY CYS SEQRES 9 B 329 LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN ILE GLY SEQRES 10 B 329 SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE ALA LYS SEQRES 11 B 329 GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL HIS ARG SEQRES 12 B 329 ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR PRO GLN SEQRES 13 B 329 HIS VAL LYS ILE THR ASP PHE GLY LEU ALA LYS LEU LEU SEQRES 14 B 329 GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY GLY LYS SEQRES 15 B 329 VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE LEU HIS SEQRES 16 B 329 ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER TYR GLY SEQRES 17 B 329 VAL THR VAL TRP GLU LEU MET THR PHE GLY SER LYS PRO SEQRES 18 B 329 TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER ILE LEU SEQRES 19 B 329 GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE CYS THR SEQRES 20 B 329 ILE ASP VAL TYR MET ILE MET VAL LYS CYS TRP MET ILE SEQRES 21 B 329 ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU ILE ILE SEQRES 22 B 329 GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG TYR LEU SEQRES 23 B 329 VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SER PRO SEQRES 24 B 329 THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP GLU GLU SEQRES 25 B 329 ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR LEU ILE SEQRES 26 B 329 PRO GLN GLN GLY HET 1C9 A9001 28 HET 1C9 B9001 28 HETNAM 1C9 (2E)-N-{4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-7- HETNAM 2 1C9 METHOXYQUINAZOLIN-6-YL}-4-(PIPERIDIN-1-YL)BUT-2- HETNAM 3 1C9 ENAMIDE HETSYN 1C9 DACOMITINIB FORMUL 3 1C9 2(C24 H25 CL F N5 O2) FORMUL 5 HOH *282(H2 O) HELIX 1 1 ASN A 700 LEU A 704 5 5 HELIX 2 2 LYS A 708 THR A 710 5 3 HELIX 3 3 ASN A 756 SER A 768 1 13 HELIX 4 4 CYS A 797 HIS A 805 1 9 HELIX 5 5 GLY A 810 ARG A 831 1 22 HELIX 6 6 ALA A 839 ARG A 841 5 3 HELIX 7 7 GLY A 857 LEU A 862 1 6 HELIX 8 8 PRO A 877 MET A 881 5 5 HELIX 9 9 ALA A 882 ARG A 889 1 8 HELIX 10 10 THR A 892 THR A 909 1 18 HELIX 11 11 PRO A 919 SER A 921 5 3 HELIX 12 12 GLU A 922 LYS A 929 1 8 HELIX 13 13 THR A 940 TRP A 951 1 12 HELIX 14 14 ASP A 954 ARG A 958 5 5 HELIX 15 15 LYS A 960 ARG A 973 1 14 HELIX 16 16 ASP A 974 TYR A 978 5 5 HELIX 17 17 GLY A 983 MET A 987 5 5 HELIX 18 18 SER A 991 ASP A 1003 1 13 HELIX 19 19 ASN B 700 LEU B 704 5 5 HELIX 20 20 LYS B 708 THR B 710 5 3 HELIX 21 21 ALA B 755 ALA B 767 1 13 HELIX 22 22 CYS B 797 HIS B 805 1 9 HELIX 23 23 GLY B 810 ARG B 831 1 22 HELIX 24 24 ALA B 839 ARG B 841 5 3 HELIX 25 25 GLY B 857 LEU B 862 1 6 HELIX 26 26 PRO B 877 MET B 881 5 5 HELIX 27 27 ALA B 882 ARG B 889 1 8 HELIX 28 28 THR B 892 THR B 909 1 18 HELIX 29 29 PRO B 919 SER B 921 5 3 HELIX 30 30 GLU B 922 LYS B 929 1 8 HELIX 31 31 THR B 940 TRP B 951 1 12 HELIX 32 32 ASP B 954 ARG B 958 5 5 HELIX 33 33 LYS B 960 ASP B 974 1 15 HELIX 34 34 PRO B 975 TYR B 978 5 4 HELIX 35 35 SER B 991 ASP B 1003 1 13 SHEET 1 A 6 ARG A 705 ILE A 706 0 SHEET 2 A 6 GLY A 779 LEU A 782 1 O ILE A 780 N ARG A 705 SHEET 3 A 6 VAL A 786 MET A 790 -1 O ILE A 789 N GLY A 779 SHEET 4 A 6 ILE A 740 GLU A 746 -1 N ALA A 743 O MET A 790 SHEET 5 A 6 THR A 725 TRP A 731 -1 N TYR A 727 O ILE A 744 SHEET 6 A 6 PHE A 712 SER A 720 -1 N LEU A 718 O VAL A 726 SHEET 1 B 2 VAL A 843 THR A 847 0 SHEET 2 B 2 HIS A 850 ILE A 853 -1 O LYS A 852 N LEU A 844 SHEET 1 C 6 ARG B 705 ILE B 706 0 SHEET 2 C 6 GLY B 779 LEU B 782 1 O ILE B 780 N ARG B 705 SHEET 3 C 6 VAL B 786 MET B 790 -1 O ILE B 789 N GLY B 779 SHEET 4 C 6 ILE B 740 LEU B 747 -1 N LYS B 745 O LEU B 788 SHEET 5 C 6 GLY B 724 TRP B 731 -1 N TYR B 727 O ILE B 744 SHEET 6 C 6 PHE B 712 SER B 720 -1 N LEU B 718 O VAL B 726 SHEET 1 D 2 VAL B 843 THR B 847 0 SHEET 2 D 2 HIS B 850 ILE B 853 -1 O LYS B 852 N LEU B 844 LINK SG CYS B 797 C23 1C9 B9001 1555 1555 1.83 LINK SG CYS A 797 C23 1C9 A9001 1555 1555 1.84 SITE 1 AC1 15 ALA A 743 LYS A 745 LEU A 788 MET A 790 SITE 2 AC1 15 GLN A 791 MET A 793 PRO A 794 GLY A 796 SITE 3 AC1 15 CYS A 797 ASP A 800 LEU A 844 THR A 854 SITE 4 AC1 15 ASP A 855 HOH A9102 HOH A9191 SITE 1 AC2 16 ALA B 743 LYS B 745 LEU B 788 MET B 790 SITE 2 AC2 16 GLN B 791 MET B 793 PRO B 794 GLY B 796 SITE 3 AC2 16 CYS B 797 ASP B 800 LEU B 844 THR B 854 SITE 4 AC2 16 ASP B 855 HOH B9104 HOH B9145 HOH B9160 CRYST1 35.848 76.385 77.961 67.17 80.53 85.67 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027896 -0.002111 -0.004163 0.00000 SCALE2 0.000000 0.013129 -0.005425 0.00000 SCALE3 0.000000 0.000000 0.014070 0.00000